FMP

FMP

Enter

HRMY - Harmony Biosciences ...

photo-url-https://images.financialmodelingprep.com/symbol/HRMY.png

Harmony Biosciences Holdings, Inc.

HRMY

NASDAQ

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

32.72 USD

0 (0%)

WACOC

Price

36.75

Beta

Diluted Shares Outstanding

45M

Costof Debt

4.09

Tax Rate

After Tax Cost Of Debt

4.09

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

2.04B

Total Equity

1.65B

Total Capital

3.69B

Debt Weighting

55.2

Equity Weighting

44.8

Wacc

5.59

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep